FR2628324B1 - Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer - Google Patents

Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer

Info

Publication number
FR2628324B1
FR2628324B1 FR8903085A FR8903085A FR2628324B1 FR 2628324 B1 FR2628324 B1 FR 2628324B1 FR 8903085 A FR8903085 A FR 8903085A FR 8903085 A FR8903085 A FR 8903085A FR 2628324 B1 FR2628324 B1 FR 2628324B1
Authority
FR
France
Prior art keywords
immunostimulant
antiviral
preparing
same
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8903085A
Other languages
English (en)
French (fr)
Other versions
FR2628324A1 (fr
Inventor
Peter Literati Nagy
Maria Boros
Jenoe Szilbereky
Istvan Racz
Gyoengyver Soos
Miklos Koller
Alan Pinter
Gabor Nemeth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOREX KFT
Original Assignee
BIOREX KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOREX KFT filed Critical BIOREX KFT
Publication of FR2628324A1 publication Critical patent/FR2628324A1/fr
Application granted granted Critical
Publication of FR2628324B1 publication Critical patent/FR2628324B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8903085A 1988-03-09 1989-03-09 Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer Expired - Fee Related FR2628324B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881132A HU209973B (en) 1988-03-09 1988-03-09 Process for production of antiviral and immunstimular pharmaceutical composition

Publications (2)

Publication Number Publication Date
FR2628324A1 FR2628324A1 (fr) 1989-09-15
FR2628324B1 true FR2628324B1 (fr) 1994-05-27

Family

ID=10952974

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8903085A Expired - Fee Related FR2628324B1 (fr) 1988-03-09 1989-03-09 Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer

Country Status (14)

Country Link
JP (1) JPH01316316A (fi)
KR (1) KR890014103A (fi)
BE (1) BE1002890A3 (fi)
CA (1) CA1334576C (fi)
CH (1) CH678918A5 (fi)
DE (1) DE3907649C2 (fi)
FI (1) FI94591C (fi)
FR (1) FR2628324B1 (fi)
GB (1) GB2216418B (fi)
HU (1) HU209973B (fi)
IT (1) IT1229562B (fi)
LU (1) LU87471A1 (fi)
NL (1) NL8900574A (fi)
SE (1) SE8900828L (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
CA2159116A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5767156A (en) * 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
WO1996030381A1 (en) * 1995-03-28 1996-10-03 Novo Nordisk A/S Immunosuppressive agents
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
BRPI0820802A2 (pt) * 2007-12-17 2015-06-16 Univ Florida Materiais e métodos para tratamento de proliferação vascular ocular patológica
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
EP3248467A1 (de) 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
EP3463310B1 (en) * 2016-05-25 2023-07-05 Evonik Operations GmbH Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
WO2019008101A1 (en) 2017-07-06 2019-01-10 Evonik Technochemie Gmbh ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS
KR102628351B1 (ko) 2017-08-15 2024-01-25 에보니크 오퍼레이션즈 게엠베하 오메가-3 지방산 아미노산 염의 높은 활성 성분 함량을 갖는 정제
MX2022001570A (es) 2019-08-08 2022-03-02 Evonik Operations Gmbh Proceso de flujo descendente para la produccion de sales de acidos grasos poliinsaturados.
US20220287345A1 (en) 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
FR2215212B1 (fi) * 1973-01-18 1976-03-05 Seperic Ch
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
GB2118437B (en) * 1982-03-01 1984-12-12 Efamol Ltd Composition for treating alcoholism
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
DE3229956A1 (de) * 1982-08-12 1984-02-16 Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf Arzneimittel mit cytostatischer wirkung
DE3514328C1 (de) * 1985-04-19 1986-09-11 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg Verwendung von L-Ornithin bei der selektiven Hemmung von cytotoxischen T-Lymphozyten-Effektorzellen
ATE88631T1 (de) * 1986-09-17 1993-05-15 Clintec Nutrition Co Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
SE8900828L (sv) 1989-09-10
GB2216418B (en) 1991-12-11
SE8900828D0 (sv) 1989-03-09
LU87471A1 (fr) 1990-10-02
IT8919704A0 (it) 1989-03-09
GB8905385D0 (en) 1989-04-19
GB2216418A (en) 1989-10-11
BE1002890A3 (fr) 1991-07-16
HUT60432A (en) 1992-09-28
FI94591C (fi) 1995-10-10
FI94591B (fi) 1995-06-30
IT1229562B (it) 1991-09-04
JPH01316316A (ja) 1989-12-21
DE3907649A1 (de) 1989-09-28
HU209973B (en) 1995-01-30
KR890014103A (ko) 1989-10-21
FI891145A (fi) 1989-09-10
FI891145A0 (fi) 1989-03-09
NL8900574A (nl) 1989-10-02
FR2628324A1 (fr) 1989-09-15
CH678918A5 (fi) 1991-11-29
CA1334576C (en) 1995-02-28
DE3907649C2 (de) 1996-07-11

Similar Documents

Publication Publication Date Title
FR2628324B1 (fr) Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer
EG19752A (en) Dialkoxy-pyridinyl-benzimidazole derivatives process for their preparation and their pharmaceutical use
ZA908157B (en) Pharmaceutical phenylpyridone derivatives
DK153787A (da) Laegemidler med langsom frigivelse
DK89090D0 (da) Farmaceutisk praeparat
PT77488B (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
FR2554717B1 (fr) Comprimes pharmaceutiques a liberation etalee et procede pour les preparer
DK705488A (da) Farmaceutisk praeparat
FR2628972B1 (fr) Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer
FR2629471B1 (fr) Procede de preparation de demi-produits en cuir
GB8924286D0 (en) Pharmaceutical composition and process for preparing the same
HUT46645A (en) Process for producing alpha-halogen-dicarboxylic acids and their derivatives and pharmaceutical compositions comprising the same
ZA88754B (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation,their use and pharmaceutical products based on these compounds
FR2692442B1 (fr) Preparation huileuse et procede pour la preparer.
HUT46644A (en) Process for producing propylophenone derivatives and pharmaceutical compositions comprising the same
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
DK139388A (da) Farmaceutisk praeparat
MA19907A1 (fr) Procede de preparation de derives de la thiatriazine et utilisation de ceux-ci dans des compositions pharmaceutiques.
PT87186A (pt) Imidazothiadiazine derivatives a process for preparing the same and their use as medicaments
MA19893A1 (fr) Procede de preparation de derives de sulfamoylbenzophenone et utilisation de ceux-ci dans des compositions pharmaceutiques.
DK276288A (da) Farmaceutisk praeparat
FR2634765B1 (fr) Procede pour la preparation de levo- et de dextro-dropropizine
DK138888A (da) Farmaceutisk praeparat
DK524587D0 (da) Laegemiddel

Legal Events

Date Code Title Description
ST Notification of lapse